BIOCE. NEW 2023 DL-,0001
BIOCE. NEW 2023 DL-,0001
Acción · US09072V6002 · BIOC · A3EG0A (XNCM)
Resumen Indicadores financieros
Sin cotización
n/a

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
- - - - -3,21 % -1,00 % -99,96 %

Perfil de la empresa para BIOCE. NEW 2023 DL-,0001 Acción

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Datos de la empresa

Nombre BIOCE. NEW 2023 DL-,0001
Empresa Biocept, Inc.
Símbolo BIOC
Sitio web https://biocept.com
Mercado principal XNCM Frankfurt
WKN A3EG0A
ISIN US09072V6002
Tipo de valor Acción
Sector Healthcare
Industria Medical - Diagnostics & Research
CEO Mr. Darrell Taylor Esq.
País Estados Unidos de América
Moneda EUR
Empleados 0,1 T
Dirección 9955 Mesa Rim Road, 92121 San Diego
Fecha de OPV 2014-02-05

Símbolos de cotización

Nombre Símbolo
NASDAQ BIOC

Otras acciones

Los inversores que tienen BIOCE. NEW 2023 DL-,0001 también tienen las siguientes acciones en su cartera:
EEDUCATION ALBERT AB
EEDUCATION ALBERT AB Acción
UBS (LUX) BOND SICAV - USD HIGH YIELD (USD) I-B-ACC
UBS (LUX) BOND SICAV - USD HIGH YIELD (USD) I-B-ACC ETF
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025